Condition: Glioma, Malignant · Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
Diffuse low-grade glioma are rare brain tumors affecting young subjects (median age at diagnosis 38 years for grade 2 and 49 years for grade 3). Cognitive symptoms are common in these patients, including memory, attention and executive function disorders. These disorders may have a deleterious impact on patients' professional, family and social lives, and have a negative impact on their quality of life. The benefits of cognitive rehabilitation have been demonstrated in other neurological pathologies. Furthermore, due to limited access to rehabilitation by neuropsychologists, some studies have evaluated the impact of digital cognitive rehabilitation programs. However, it cannot replace human support.
This description comes directly from the study's public registry record.
Aurore MOUSSION · 467612446 · Aurore.Moussion@icm.unicancer.fr
Always discuss trial participation with your own doctor first.
| Institut régional du Cancer de Montpellier | Montpellier, Hérault, France | Recruiting |
| CHU Amiens | Amiens, France | Not Yet Recruiting |
| CHU Bordeaux | Bordeaux, France | Not Yet Recruiting |
| CHU Lyon | Lyon, France | Not Yet Recruiting |
| Hôpital de la Timone | Marseille, France | Not Yet Recruiting |
| CHU Nancy | Nancy, France | Not Yet Recruiting |
| CHU Nîmes | Nîmes, France | Not Yet Recruiting |
| Institut Claudius Régaud | Toulouse, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06468176